Mesa Laboratories, Inc.
MLAB
$77.77
-$0.83-1.06%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.77% | 39.96% | 97.21% | -179.21% | 378.70% |
| Total Depreciation and Amortization | -3.61% | 9.00% | 19.09% | -39.25% | -25.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 199.94% | -138.38% | -98.97% | 2,237.21% | -58.25% |
| Change in Net Operating Assets | 9.31% | -2,252.37% | 13.14% | 3,559.22% | -342.34% |
| Cash from Operations | 55.99% | -82.38% | -1.69% | 59.85% | -46.08% |
| Capital Expenditure | 38.93% | -13.24% | -41.50% | 27.93% | -182.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 38.93% | -13.24% | -336.38% | 98.99% | -182.02% |
| Total Debt Issued | -- | -85.71% | -- | -100.00% | -- |
| Total Debt Repaid | -1,290.84% | 90.82% | -55.98% | -8.31% | -48.74% |
| Issuance of Common Stock | -- | -- | 638.55% | -- | -- |
| Repurchase of Common Stock | -- | -- | -21.84% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.85% | -1.16% | -0.69% | -0.81% | -0.46% |
| Other Financing Activities | -83.71% | -937.73% | 531.16% | 106.90% | -201.66% |
| Cash from Financing | 8.44% | 10.53% | -25.21% | -117.42% | -54.86% |
| Foreign Exchange rate Adjustments | -110.48% | 957.71% | 333.16% | -138.97% | 390.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 79.27% | -2,441.86% | -36,250.00% | 189.53% | -227.58% |